News Website

Endometrial Ablation Market Expected to Grow at 5.83 Percent - openPR

Endometrial Ablation Market Expected to Grow at 5.83 Percent openPR

Published: March 21, 2025, 8:45 a.m.

Read Full Article

Endometrial immune assessment in patients with a history of previous euploid blastocyst failure - Frontiers

Endometrial immune assessment in patients with a history of previous euploid blastocyst failure Frontiers

Published: March 20, 2025, 7:39 p.m.

Read Full Article

Cell map offers insights into endometrial dysfunction in women with PCOS - News-Medical.Net

Cell map offers insights into endometrial dysfunction in women with PCOS News-Medical.Net

Published: March 20, 2025, 5:54 p.m.

Read Full Article

High-intensity focused ultrasound with endometrial thermal balloon ablation efficacious and safe for... - Medical Dialogues

High-intensity focused ultrasound with endometrial thermal balloon ablation efficacious and safe for... Medical Dialogues

Published: March 20, 2025, 4:30 p.m.

Read Full Article

Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 - Precedence Research

Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 Precedence Research

Published: March 20, 2025, 1:41 p.m.

Read Full Article

Endometrial Cell Atlas in PCOS Could Improve Treatment - Mirage News

Endometrial Cell Atlas in PCOS Could Improve Treatment Mirage News

Published: March 20, 2025, 10:02 a.m.

Read Full Article

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …

Published: March 19, 2025, 10:53 p.m.

Read Full Article

AI model detects endometrial cancer at almost 100 per cent accuracy - NT News

AI model detects endometrial cancer at almost 100 per cent accuracy NT News

Published: March 19, 2025, 3:45 p.m.

Read Full Article

Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı

Published: March 19, 2025, 2:55 p.m.

Read Full Article

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.

Read Full Article

Latest Articles

Endometrial Ablation Market Expected to Grow at 5.83 Percent - openPR

Endometrial immune assessment in patients with a history of previous euploid blastocyst failure - Frontiers

Cell map offers insights into endometrial dysfunction in women with PCOS - News-Medical.Net

High-intensity focused ultrasound with endometrial thermal balloon ablation efficacious and safe for... - Medical Dialogues

Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 - Precedence Research

Endometrial Cell Atlas in PCOS Could Improve Treatment - Mirage News

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

AI model detects endometrial cancer at almost 100 per cent accuracy - NT News

Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Subscribe to Our Newsletter